Q: Morning 5i,
How serious do you think this DRI.UN management fiasco is? Do you foresee a long time in the penalty box for the name (it fell drastically today and has a lot to make up to get back) or do you think there will be a reasonably quick recovery?
(I've got a fair amount tied up in DRI.UN and got quite a shock when I looked at my accounts this morning, so I'm in need of a level headed take on the situation.)
Thanks,
Peter
Q: Morning 5i,
I haven't been able to find DHT.UN results for its quarterly earnings which I think were released on May 6. Perhaps I just don't know where to look. In any event could you please provide your analysis of the results along with any general or specific commentary you might have about the name. I've done well by it and would like to continue holding unless something material has fundamentally changed, or looks like it might.
Thanks,
Peter
Q: Could you please comment on last week's NR from DHT.UN (see below). The market responded favourably and so did the analysts with a multitude of raised targets. Thanks as always.
– Increasing capital deployment guidance to over US$1.25 billion deployed for the five years ending 2025 –
– Now expecting high-teens Royalty Income CAGR through 2025 and mid- to high-single digit Royalty Income CAGR through 2030, excluding any new transactions –
Q: Your thoughts on DRI Healthcare Trust please. I am reading outperform ratings in the Globe and Mail. It is a comfort to have 5i to ask questions - thank you. Barbara
I'm a bit confused re: the dividend for DRI Healthcare. Your profile shows a current dividend of about 9.6% (even higher for DHT.U) but other sources such as G&M and Morningstar show it at 3.49%.
Q: Regarding your answer to Peter, call me cynical but this company inexplicably began a steady decline a month ago, followed by a steep decline yesterday before the public announcement of the bought deal. It looks to my suspicious mind like some people had inside information and acted on that knowledge.
Q: Hi again 5i,
Re the question I just sent in asking for information about yesterday's sharp price decline and trading halt for DHT.UN, I've now learned of the bought-deal arrangement that was announced yesterday and which led me to sustain a significant paper loss on my first day of ownership.
So now my question is - could you please provide your analysis of the long-term implications of the bought deal for DHT.UN.
Thanks 5i.
Peter
Q: Hi 5i,
On June 29 you were asked for the best metrics to evaluate a royalty company like DHT.UN and your answer was:
We think the best metrics are distribution as a percentage of free cash flow (targeted between 30 and 35% as per management), new royalty transactions or pipeline, and EBITDA and FCF multiples.
Could you please supply the current numbers and information to fill in those metrics for DHT.UN, along with your commentary about what they lead you to conclude about the current health and future prospects of DHT.UN.
Q: Hi 5i,
Do you still favour LIFE over DHT.un? And what about holding both in a TFSA?
And what is your opinion of PPL? It never goes up? I also have ENB but they have the underwater pipeline issue. What would be alternatives?
Many thanks for your patience and great suggestions.
Connie
Q: You indicated back in 2021 that you would prefer this over DHT.U. Does this still stand as your preference and what do you think of DHT.UN as an income play (overall safety over the next 3-5 years) ?
Q: I thought I saw that a new analyst is following DRI, calling it a rare gem in the sector with a combination of higher yield but still having growth potential. It is still a fair bit under it’s IPO price, and too small to attract much attention I would think. I read your previous comments on this company, wondering if you having any other “colour commentary”? I’m tempted to put it into a TFSA, especially if the typical growth ideas may be facing headwinds for awhile. Do you know anything about the management, or the company’s performance/history before IPO’ing?
Q: Hi Everyone,
Lately PKI seems to be on a downward trajectory. I am wondering if it's time to sell the stock, or do you see it rebounding this year.?
Also, I would like your opinion on DHT.UN. I know nothing about this stock,but it has a very attractive dividend. Does it have a lot of debt? How safe is its dividend and does it have any growth potential?
I appreciation your opinion.
Thanks,
Jane
Q: Good morning 5i,
I'd like to put some funds into healthcare for a what expect to be 3 to 5 years. Currently, HHL will provide around 8.6% per annum income, but capital gain potential seems limited. DHT.UN meanwhile is currently yielding 2.4% but the analysts I have access to appear optimistic for future share price growth.
I definitely like the HHL income (which I would reinvest in the name quarterly) but wonder if, in your opinion based on current available info, whether or not it would be overly risky to lock down some DHT.UN at current levels instead. I guess an earnings report or two from DHT.UN illustrating how 2021 has gone so far might be helpful in looking ahead, but I'm not aware of any ...?
Thanks for your thoughts.
Peter
Q: Hello team,
I have been reading positive reports on DRI Healthcare. Can you tell me the difference between DHT.U and DHT.UN and which would be the preferred investment? Do you believe it is worth taking a small position in this company at this time?
Thanks